Role of Ca2+-dependent K+ channels in erythrocyte lysate-induced contraction of rabbit cerebral artery

Neurological Research

Volumn 21, Issue 7, 1999, Pages 705-711

  Kim, Chul Jin ^b,c   Kim, Kee Won ^b   Park, Jin Woo ^b   Lee, Jung Chung ^b   Zhang, John H ^a,b  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b Chonbuk National University   (South Korea)

^c Chonbuk National University Medical School   (South Korea)

Author keywords

Cerebral vasospasm; Erythrocyte lysate; Iberiotoxin; K(Ca) channels; NS1619

Indexed keywords

1 (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL) 5 TRIFLUOROMETHYL 2(3H) BENZIMIDAZOLONE; CALCIUM ION; IBERIOTOXIN; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM CHLORIDE; POTASSIUM ION;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BRAIN ARTERY; FEMALE; HEMOLYSATE; MALE; NONHUMAN; RABBIT; VASOSPASM;

EID: 0032711003     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1080/01616412.1999.11741002     Document Type: Article

References (28)

1. Bevan JA, Bevan RD. Arterial wall changes in chronic cerebro-vasospasm: In vitro and in vivo pharmacological evidence. Annu Rev Pharmacol Toxicol 1988; 28: 311-329
2. Findlay JM, Macdonald RL, Weir BK. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab Rev 1991; 3: 336-361
3. Macdonald RL, Wang X, Zhang J, Marton LS. Molecular changes with subarachnoid hemorrhage and vasospasm. In: Raffel C, Harsh G, eds. The Molecular Biology of Neurosurgical Disease, Baltimore: Williams & Wilkins, 1996: pp. 278-293
4. Mayberg MR, Okada T, Bark DH. The role of hemoglobin in arterial narrowing after subarachnoid hemorrhage. J Neurosurg 1990; 72: 634-640
5. Solomon RA, Antunes JL, Chen RY, Bland L, Chien S. Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage. A new animal model. Stroke 1985; 16: 58-64
6. Zhang J, Lewis AI, Bernanke DH, Zubkov AY, Clower BR. Stroke: Anatomy of a catastrophic event. Anat Rec (New Anat) 1998; 253: 58-63
7. Harder DR, Dernach P, Waters A. Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. J Clin Invest 1987; 80: 875-880
8. Peterson JW, Bun T, Zervas NT. Plasma-borne vasoactivity and modulation by the endothelium as determinants of cerebrovascular tone: Possible role during cerebral vasospasm. In: Raichle ME, Powers WI, eds. Cerebrovascular Disease, New York: Raven Press, 1987: pp. 187-199
9. m. Stroke 1985; 16: 990-997
10. Wellum GR, Peterson JW, Zervas NT. The relevance of in vitro smooth muscle experiments to cerebral vasospasm. Stroke 1985; 16: 573-581
11. Zuccarello M, Bonasso CL, Sperelakis N, Rapoport RM. Role of membrane potential in vasospasm after subarachnoid hemorrhage. In: Findlay JM, ed. Cerebral Vasospasm, Amsterdam: Elsevier, 1993: pp. 229-233
12. Harder DR, Alkayed NJ, Lange AR, Gebremedhin D, Roman RJ. Functional hyperemia in the brain hypothesis for astrocyte-derived vasodilator metabolites. Stroke 1998; 28: 229-234
13. Kitazono T, Faraci FM, Taguchi H, Heistad DD. Role of potassium channels in cerebral blood vessels. Stroke 1995; 26: 1713-1723
14. 2+-activated potassium channels and ATP-sensitive potassium channels as modulators of vascular tone. Trends Cardiovasc Med 1993; 3: 16-22
15. Zhang H, Cook D. Cerebral vascular smooth muscle potassium channels and their possible role in the management of vasospasm. Pharmacol Toxicol 1994; 75: 327-336
16. Kwan AL, Lin CL, Yanamoto H, Howng SL, Kassell NF, Lee KS. Systemic administration of the potassium channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 1998; 42: 347-351
17. + channel activator cromakalim. Stroke 1996; 27: 311-316
18. Matsui T, Nagafuji T, Uchida H, Miyauchi T, Asano T. The effect of nicorandil on chronic cerebral vasospasm. In: Findlay JM, ed. Cerebral Vasospasm, Amsterdam: Elsevier, 1993: pp. 357-360
19. Yamada K, Ohta T, Schimizu K, Yasuda A. Effect of nicorandil on cerebral vasospasm. Jpn J Clin Pharmacol Ther 1989; 20: 381-390
20. Kim CJ, Kim KW, Park JW, Lee JC, Zhang JH. Role of tyrosine kinase in erythrocyte lysate-induced contraction in rabbit cerebral arteries. J Neurosurg 1998; 89: 289-296
21. + channels? Trends Pharmacol Sci 1993; 14: 332-337
22. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science 1992; 256: 532-535
23. Gebremedhin D, Ma YH, Falck JR, Roman RJ, VanRollins M, Harder DR. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol 263: H519-H525
24. Onoue H, Katusic Z. Role of potassium channels in relaxations of canine middle cerebral arteries induced by nitric oxide donors. Stroke 1997; 28: 1264-1271
25. Robertson BE, Schubert R, Hescheler J, Nelson MT. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol 1993; 265: C299-C303
26. + channels. Nature 1990; 344: 770-773
27. Ca channel activator, NS1619, on rat cerebral artery smooth muscle. Br J Pharmacol 1996; 117: 119-129
28. Ca channel opener in vascular smooth muscle. Br J Pharmacol 1994; 113: 1538-1547